FOR IMMEDIATE RELEASE
March 15, 2019
NCODA Announces Dr. Mario Lacouture as Director of the Medical Advisory Board for Treatment Support Program
Cazenovia, NY – The National Community Oncology Dispensing
Association, Inc. (NCODA) Executive Council is pleased to announce that Mario
Lacouture, M.D. will be joining the Treatment Support Program as Director of the Medical Advisory Board.
Dr. Lacouture is a board-certified
dermatologist at Memorial Sloan Kettering Cancer Center in New York City, where
he serves as Director of the Oncodermatology Program. Dr. Lacouture’s clinical
career has focused on the recognition and management of side effects resulting
from cancer treatments, affecting the skin, hair, and nails of cancer patients
“It is a great day for NCODA!”
proclaimed Michael Reff, Founder and Executive Director of NCODA, after
learning that Mario Lacouture would be joining the Treatment Support Program team.
Dr. Lacouture will start his work with the program in March. In his role as Director of the Medical Advisory Board, Dr.
Lacouture will be providing expertise and guidance to the program committee.
The mission of NCODA’s Treatment Support
Program is to provide patients and caregivers with resources
that make sense for adherence and adverse effect management during
treatment with anticancer medications. The priority is to equip healthcare professionals
and patients with educational information and products that will be needed
during the course of treatment. NCODA’s Treatment Support Kits are a
fundamental component of the program.
TSK committee co-chairs Chris Kepinski,
PharmD [Southern Oncology Specialists, NC] and Jamie Fritz, PharmD [Compass
Oncology, WA] also see Dr. Lacouture as a great asset to the program. “Having
an expert on the team who has seen first-hand how adverse effects of cancer
treatments impact patient adherence is extremely important,” Kepinski said.
“The work that NCODA is doing with the
Treatment Support Program is something that I fully support,” said Lacouture. “What
better way to help patients than by providing them with the information and
products they need to maintain their quality of life and health throughout
their treatment course.”
For more information about NCODA’s Treatment Support Program visit: https://www.ncoda.org/treatment-support-kits.
See Full Press Release Here.